ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibodies in Oncology Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-6K12720
Home | Market Reports | Health| Health Conditions| Cancer
Global Antibodies in Oncology Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Antibodies in Oncology Market Research Report 2025

Code: QYRE-Auto-6K12720
Report
June 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis International AG
GlaxoSmithKline PLC
Biogen idec Inc.
Bristol-Myers Squibb Co
Astrazeneca plc
Celltrion
3SBio Inc
Celgen Biopharma
Dr. Reddy's

Antibodies in Oncology Market

The global market for Antibodies in Oncology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Antibodies in Oncology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antibodies in Oncology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Antibodies in Oncology in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Antibodies in Oncology include Novartis International AG, GlaxoSmithKline plc, Biogen Idec Inc., Bristol Myers Squibb Co., AstraZeneca plc., Celltrion, 3SBIO, Celgen Biopharma, Dr Reddy’s, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antibodies in Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibodies in Oncology.
The Antibodies in Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibodies in Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibodies in Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antibodies in Oncology Market Report

Report Metric Details
Report Name Antibodies in Oncology Market
Segment by Type
  • Murine Antibodies
  • Chimeric and Humanised Antibodies
  • Fully Humanized Antibodies
  • Others
Segment by Application
  • Hospitals
  • Academic Institutes
  • Clinics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis International AG, GlaxoSmithKline plc, Biogen Idec Inc., Bristol Myers Squibb Co., AstraZeneca plc., Celltrion, 3SBIO, Celgen Biopharma, Dr Reddy’s
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antibodies in Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antibodies in Oncology Market report?

Ans: The main players in the Antibodies in Oncology Market are Novartis International AG, GlaxoSmithKline plc, Biogen Idec Inc., Bristol Myers Squibb Co., AstraZeneca plc., Celltrion, 3SBIO, Celgen Biopharma, Dr Reddy’s

What are the Application segmentation covered in the Antibodies in Oncology Market report?

Ans: The Applications covered in the Antibodies in Oncology Market report are Hospitals, Academic Institutes, Clinics

What are the Type segmentation covered in the Antibodies in Oncology Market report?

Ans: The Types covered in the Antibodies in Oncology Market report are Murine Antibodies, Chimeric and Humanised Antibodies, Fully Humanized Antibodies, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibodies in Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Murine Antibodies
1.2.3 Chimeric and Humanised Antibodies
1.2.4 Fully Humanized Antibodies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antibodies in Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Academic Institutes
1.3.4 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibodies in Oncology Market Perspective (2020-2031)
2.2 Global Antibodies in Oncology Growth Trends by Region
2.2.1 Global Antibodies in Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antibodies in Oncology Historic Market Size by Region (2020-2025)
2.2.3 Antibodies in Oncology Forecasted Market Size by Region (2026-2031)
2.3 Antibodies in Oncology Market Dynamics
2.3.1 Antibodies in Oncology Industry Trends
2.3.2 Antibodies in Oncology Market Drivers
2.3.3 Antibodies in Oncology Market Challenges
2.3.4 Antibodies in Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibodies in Oncology Players by Revenue
3.1.1 Global Top Antibodies in Oncology Players by Revenue (2020-2025)
3.1.2 Global Antibodies in Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Antibodies in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antibodies in Oncology Revenue
3.4 Global Antibodies in Oncology Market Concentration Ratio
3.4.1 Global Antibodies in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibodies in Oncology Revenue in 2024
3.5 Global Key Players of Antibodies in Oncology Head office and Area Served
3.6 Global Key Players of Antibodies in Oncology, Product and Application
3.7 Global Key Players of Antibodies in Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibodies in Oncology Breakdown Data by Type
4.1 Global Antibodies in Oncology Historic Market Size by Type (2020-2025)
4.2 Global Antibodies in Oncology Forecasted Market Size by Type (2026-2031)
5 Antibodies in Oncology Breakdown Data by Application
5.1 Global Antibodies in Oncology Historic Market Size by Application (2020-2025)
5.2 Global Antibodies in Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antibodies in Oncology Market Size (2020-2031)
6.2 North America Antibodies in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antibodies in Oncology Market Size by Country (2020-2025)
6.4 North America Antibodies in Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibodies in Oncology Market Size (2020-2031)
7.2 Europe Antibodies in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antibodies in Oncology Market Size by Country (2020-2025)
7.4 Europe Antibodies in Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibodies in Oncology Market Size (2020-2031)
8.2 Asia-Pacific Antibodies in Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antibodies in Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Antibodies in Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibodies in Oncology Market Size (2020-2031)
9.2 Latin America Antibodies in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antibodies in Oncology Market Size by Country (2020-2025)
9.4 Latin America Antibodies in Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibodies in Oncology Market Size (2020-2031)
10.2 Middle East & Africa Antibodies in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antibodies in Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Antibodies in Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis International AG
11.1.1 Novartis International AG Company Details
11.1.2 Novartis International AG Business Overview
11.1.3 Novartis International AG Antibodies in Oncology Introduction
11.1.4 Novartis International AG Revenue in Antibodies in Oncology Business (2020-2025)
11.1.5 Novartis International AG Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Details
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Antibodies in Oncology Introduction
11.2.4 GlaxoSmithKline plc Revenue in Antibodies in Oncology Business (2020-2025)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Biogen Idec Inc.
11.3.1 Biogen Idec Inc. Company Details
11.3.2 Biogen Idec Inc. Business Overview
11.3.3 Biogen Idec Inc. Antibodies in Oncology Introduction
11.3.4 Biogen Idec Inc. Revenue in Antibodies in Oncology Business (2020-2025)
11.3.5 Biogen Idec Inc. Recent Development
11.4 Bristol Myers Squibb Co.
11.4.1 Bristol Myers Squibb Co. Company Details
11.4.2 Bristol Myers Squibb Co. Business Overview
11.4.3 Bristol Myers Squibb Co. Antibodies in Oncology Introduction
11.4.4 Bristol Myers Squibb Co. Revenue in Antibodies in Oncology Business (2020-2025)
11.4.5 Bristol Myers Squibb Co. Recent Development
11.5 AstraZeneca plc.
11.5.1 AstraZeneca plc. Company Details
11.5.2 AstraZeneca plc. Business Overview
11.5.3 AstraZeneca plc. Antibodies in Oncology Introduction
11.5.4 AstraZeneca plc. Revenue in Antibodies in Oncology Business (2020-2025)
11.5.5 AstraZeneca plc. Recent Development
11.6 Celltrion
11.6.1 Celltrion Company Details
11.6.2 Celltrion Business Overview
11.6.3 Celltrion Antibodies in Oncology Introduction
11.6.4 Celltrion Revenue in Antibodies in Oncology Business (2020-2025)
11.6.5 Celltrion Recent Development
11.7 3SBIO
11.7.1 3SBIO Company Details
11.7.2 3SBIO Business Overview
11.7.3 3SBIO Antibodies in Oncology Introduction
11.7.4 3SBIO Revenue in Antibodies in Oncology Business (2020-2025)
11.7.5 3SBIO Recent Development
11.8 Celgen Biopharma
11.8.1 Celgen Biopharma Company Details
11.8.2 Celgen Biopharma Business Overview
11.8.3 Celgen Biopharma Antibodies in Oncology Introduction
11.8.4 Celgen Biopharma Revenue in Antibodies in Oncology Business (2020-2025)
11.8.5 Celgen Biopharma Recent Development
11.9 Dr Reddy’s
11.9.1 Dr Reddy’s Company Details
11.9.2 Dr Reddy’s Business Overview
11.9.3 Dr Reddy’s Antibodies in Oncology Introduction
11.9.4 Dr Reddy’s Revenue in Antibodies in Oncology Business (2020-2025)
11.9.5 Dr Reddy’s Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Novartis International AG
GlaxoSmithKline PLC
Biogen idec Inc.
Bristol-Myers Squibb Co
Astrazeneca plc
Celltrion
3SBio Inc
Celgen Biopharma
Dr. Reddy's
List of Tables
 Table 1. Global Antibodies in Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Murine Antibodies
 Table 3. Key Players of Chimeric and Humanised Antibodies
 Table 4. Key Players of Fully Humanized Antibodies
 Table 5. Key Players of Others
 Table 6. Global Antibodies in Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Antibodies in Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Antibodies in Oncology Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Antibodies in Oncology Market Share by Region (2020-2025)
 Table 10. Global Antibodies in Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Antibodies in Oncology Market Share by Region (2026-2031)
 Table 12. Antibodies in Oncology Market Trends
 Table 13. Antibodies in Oncology Market Drivers
 Table 14. Antibodies in Oncology Market Challenges
 Table 15. Antibodies in Oncology Market Restraints
 Table 16. Global Antibodies in Oncology Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Antibodies in Oncology Market Share by Players (2020-2025)
 Table 18. Global Top Antibodies in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibodies in Oncology as of 2024)
 Table 19. Ranking of Global Top Antibodies in Oncology Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Antibodies in Oncology Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Antibodies in Oncology, Headquarters and Area Served
 Table 22. Global Key Players of Antibodies in Oncology, Product and Application
 Table 23. Global Key Players of Antibodies in Oncology, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Antibodies in Oncology Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Antibodies in Oncology Revenue Market Share by Type (2020-2025)
 Table 27. Global Antibodies in Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Antibodies in Oncology Revenue Market Share by Type (2026-2031)
 Table 29. Global Antibodies in Oncology Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Antibodies in Oncology Revenue Market Share by Application (2020-2025)
 Table 31. Global Antibodies in Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Antibodies in Oncology Revenue Market Share by Application (2026-2031)
 Table 33. North America Antibodies in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Antibodies in Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Antibodies in Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Antibodies in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Antibodies in Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Antibodies in Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Antibodies in Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Antibodies in Oncology Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Antibodies in Oncology Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Antibodies in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Antibodies in Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antibodies in Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Antibodies in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Antibodies in Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Antibodies in Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Novartis International AG Company Details
 Table 49. Novartis International AG Business Overview
 Table 50. Novartis International AG Antibodies in Oncology Product
 Table 51. Novartis International AG Revenue in Antibodies in Oncology Business (2020-2025) & (US$ Million)
 Table 52. Novartis International AG Recent Development
 Table 53. GlaxoSmithKline plc Company Details
 Table 54. GlaxoSmithKline plc Business Overview
 Table 55. GlaxoSmithKline plc Antibodies in Oncology Product
 Table 56. GlaxoSmithKline plc Revenue in Antibodies in Oncology Business (2020-2025) & (US$ Million)
 Table 57. GlaxoSmithKline plc Recent Development
 Table 58. Biogen Idec Inc. Company Details
 Table 59. Biogen Idec Inc. Business Overview
 Table 60. Biogen Idec Inc. Antibodies in Oncology Product
 Table 61. Biogen Idec Inc. Revenue in Antibodies in Oncology Business (2020-2025) & (US$ Million)
 Table 62. Biogen Idec Inc. Recent Development
 Table 63. Bristol Myers Squibb Co. Company Details
 Table 64. Bristol Myers Squibb Co. Business Overview
 Table 65. Bristol Myers Squibb Co. Antibodies in Oncology Product
 Table 66. Bristol Myers Squibb Co. Revenue in Antibodies in Oncology Business (2020-2025) & (US$ Million)
 Table 67. Bristol Myers Squibb Co. Recent Development
 Table 68. AstraZeneca plc. Company Details
 Table 69. AstraZeneca plc. Business Overview
 Table 70. AstraZeneca plc. Antibodies in Oncology Product
 Table 71. AstraZeneca plc. Revenue in Antibodies in Oncology Business (2020-2025) & (US$ Million)
 Table 72. AstraZeneca plc. Recent Development
 Table 73. Celltrion Company Details
 Table 74. Celltrion Business Overview
 Table 75. Celltrion Antibodies in Oncology Product
 Table 76. Celltrion Revenue in Antibodies in Oncology Business (2020-2025) & (US$ Million)
 Table 77. Celltrion Recent Development
 Table 78. 3SBIO Company Details
 Table 79. 3SBIO Business Overview
 Table 80. 3SBIO Antibodies in Oncology Product
 Table 81. 3SBIO Revenue in Antibodies in Oncology Business (2020-2025) & (US$ Million)
 Table 82. 3SBIO Recent Development
 Table 83. Celgen Biopharma Company Details
 Table 84. Celgen Biopharma Business Overview
 Table 85. Celgen Biopharma Antibodies in Oncology Product
 Table 86. Celgen Biopharma Revenue in Antibodies in Oncology Business (2020-2025) & (US$ Million)
 Table 87. Celgen Biopharma Recent Development
 Table 88. Dr Reddy’s Company Details
 Table 89. Dr Reddy’s Business Overview
 Table 90. Dr Reddy’s Antibodies in Oncology Product
 Table 91. Dr Reddy’s Revenue in Antibodies in Oncology Business (2020-2025) & (US$ Million)
 Table 92. Dr Reddy’s Recent Development
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Antibodies in Oncology Picture
 Figure 2. Global Antibodies in Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antibodies in Oncology Market Share by Type: 2024 VS 2031
 Figure 4. Murine Antibodies Features
 Figure 5. Chimeric and Humanised Antibodies Features
 Figure 6. Fully Humanized Antibodies Features
 Figure 7. Others Features
 Figure 8. Global Antibodies in Oncology Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Antibodies in Oncology Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Academic Institutes Case Studies
 Figure 12. Clinics Case Studies
 Figure 13. Antibodies in Oncology Report Years Considered
 Figure 14. Global Antibodies in Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Antibodies in Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Antibodies in Oncology Market Share by Region: 2024 VS 2031
 Figure 17. Global Antibodies in Oncology Market Share by Players in 2024
 Figure 18. Global Top Antibodies in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibodies in Oncology as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Antibodies in Oncology Revenue in 2024
 Figure 20. North America Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Antibodies in Oncology Market Share by Country (2020-2031)
 Figure 22. United States Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Antibodies in Oncology Market Share by Country (2020-2031)
 Figure 26. Germany Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Antibodies in Oncology Market Share by Region (2020-2031)
 Figure 34. China Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Antibodies in Oncology Market Share by Country (2020-2031)
 Figure 42. Mexico Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Antibodies in Oncology Market Share by Country (2020-2031)
 Figure 46. Turkey Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Antibodies in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Novartis International AG Revenue Growth Rate in Antibodies in Oncology Business (2020-2025)
 Figure 50. GlaxoSmithKline plc Revenue Growth Rate in Antibodies in Oncology Business (2020-2025)
 Figure 51. Biogen Idec Inc. Revenue Growth Rate in Antibodies in Oncology Business (2020-2025)
 Figure 52. Bristol Myers Squibb Co. Revenue Growth Rate in Antibodies in Oncology Business (2020-2025)
 Figure 53. AstraZeneca plc. Revenue Growth Rate in Antibodies in Oncology Business (2020-2025)
 Figure 54. Celltrion Revenue Growth Rate in Antibodies in Oncology Business (2020-2025)
 Figure 55. 3SBIO Revenue Growth Rate in Antibodies in Oncology Business (2020-2025)
 Figure 56. Celgen Biopharma Revenue Growth Rate in Antibodies in Oncology Business (2020-2025)
 Figure 57. Dr Reddy’s Revenue Growth Rate in Antibodies in Oncology Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Antibodies Market Research Report 2024
Global Cancer Antibody Drug Conjugates Market Research Report 2024
Global Monoclonal Antibodies Product Market Research Report 2024
Global Antibody Testing Market Research Report 2024
Global Research Antibodies Market Research Report 2025
Global Ready to Use Antibodies Market Research Report 2025
Global Trial Size Antibodies Market Research Report 2024
Global C Myc Antibody Market Research Report 2024
Global Antibody Microarrays Market Research Report 2025
Global ALK 1 Antibody Market Research Report 2024
Global Antibody Array Market Research Report 2025
Global EGFR Antibody Market Research Report 2024
Global Oncology and Cancer Treatment Drug Market Research Report 2024
Global Albumin Antibody Market Research Report 2024
Global IHC Antibody Market Research Report 2024
Global Secondary Antibodies Market Research Report 2025
Global Secondary Antibody Market Research Report 2024
Global Antibody Discovery Platforms Market Research Report 2025
Global Cancer Oncology Testing Market Research Report 2024
Global Monoclonal Antibody for Multiple Myeloma Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions